The exercise period for warrants of series TO1 (see our previous comment) started on 16/9 and ended on 7/10. 97.6% of warrant holders subscribed for new shares, as a total of 2,767,551 warrants are exercised. The exercise price was DKK 17.2/share and Curasight will receive c. DKK 44.6 m after issue costs. This is around DKK 10m more than our conservatively assumed DKK 33m and we consider it good news that investors consistently are willing to support the company.

Länk till analysen